Dividend Payout (Interim Dividend)
SoftBank Group Corp. (“SBG”) announced today that its Board of Directors resolved the distribution of interim dividend from surplus with a record date of September 30, 2024 as follows. The amount of dividend per share is in line with the forecast of dividend announced in “Consolidated Financial Report for the Fiscal Year Ended March 31, 2024,” dated May 13, 2024.
1. Details of Dividend
Dividend to be distributed | Latest forecast (as of May 13, 2024) | Reference: Fiscal year ended March 2024 | ||
---|---|---|---|---|
Interim | Year-end | |||
Record date | September 30, 2024 | Same as on the left | September 30, 2023 | March 31, 2024 |
Dividend per share | JPY 22.00 | Same as on the left | JPY 22.00 | JPY 22.00 |
Total cash dividend | JPY 31,835 million | - | JPY 32,246 million | JPY 32,250 million |
Payable date | December 3, 2024 | - | December 8, 2023 | June 24, 2024 |
Dividend resource | Retained earnings | - | Retained earnings |
- The amounts of total cash dividend are rounded off to the nearest unit.
2. Breakdown of Annual Dividend
Dividend per share | |||
---|---|---|---|
Record date | Interim | Year-end | Total |
Fiscal year ending March 2025 (forecast) | JPY 22.00 | JPY 44.00 | |
Fiscal year ending March 2025 (actual) | JPY 22.00 | ||
Fiscal year ended March 2024 (actual) | JPY 22.00 | JPY 22.00 | JPY 44.00 |
-
Releases, announcements, presentations and other information available from this page and elsewhere on this website were prepared based on information available and views held at the time of preparation and speak only as of the respective dates on which they are filed or used by SoftBank Group Corp. or the applicable group company, as the case may be. Such information is subject to change and may become out-of-date. Such information may also contain forward-looking statements which are by their nature subject to various risks and uncertainties that may cause actual results and future developments to differ materially from those expressed or implied by such statements. Please read legal notices in its entirety prior to viewing any information available on this website.